Physician profile
Deanna Davidson
NPI 1457317075
$287.42
in general payments reported to CMS, 2019-2025
14 companies · $36.80 in 2025
The $36.80 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.14 · 2020: $14.96 · 2021: $66.24 · 2022: $27.79 · 2023: $75.49 · 2025: $36.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $39.15 | 2021-2025 | Zynyz, Monjuvi |
| Dendreon Pharmaceuticals LLC | $36.77 | 2019 | |
| Novartis Pharmaceuticals Corporation | $28.93 | 2022-2023 | |
| Abbvie INC. | $27.24 | 2023 | Venclexta |
| Merck Sharp & Dohme LLC | $20.61 | 2021 | |
| Blue Earth Diagnostics | $17.45 | 2019 | |
| Glaxosmithkline, LLC. | $17.20 | 2023 | |
| Alexion Pharmaceuticals, INC. | $15.66 | 2023 | Ultomiris |
| Ipsen Biopharmaceuticals, INC | $15.27 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.26 | 2025 | |
| Celgene Corporation | $14.96 | 2020 | |
| Agios Pharmaceuticals, INC. | $14.25 | 2022 | |
| Seagen INC. | $12.75 | 2021 | |
| 180 Medical, INC. | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deanna Davidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.